{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:51:53Z","timestamp":1787316713654,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774165"],"award-info":[{"award-number":["81774165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873206"],"award-info":[{"award-number":["81873206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515010865"],"award-info":[{"award-number":["2019A1515010865"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515012173"],"award-info":[{"award-number":["2021A1515012173"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2020440"],"award-info":[{"award-number":["A2020440"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20191085"],"award-info":[{"award-number":["20191085"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.joim.2021.07.004","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T21:22:57Z","timestamp":1627593777000},"page":"428-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4\/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Mao-xing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui-yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-jun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-qian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-fang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-he","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.joim.2021.07.004_b0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0020","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.joim.2021.07.004_b0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrgastro.2017.181","article-title":"NAFLD in 2017: novel insights into mechanisms of disease progression","volume":"15","author":"Khan","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6037","key":"10.1016\/j.joim.2021.07.004_b0030","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.joim.2021.07.004_b0035","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"NAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.joim.2021.07.004_b0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in US veterans is associated with non-alcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.joim.2021.07.004_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.joim.2021.07.004_b0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/apt.14119","article-title":"Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease","volume":"46","author":"Pang","year":"2017","journal-title":"Aliment Pharm Ther"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte","year":"2010","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12876-018-0850-7","article-title":"Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice","volume":"18","author":"Niu","year":"2018","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29735-6","article-title":"Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin","volume":"8","author":"Ogawa","year":"2018","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.joim.2021.07.004_b0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0080","first-page":"1","article-title":"New insights into Nod-like receptors (NLRs) in liver diseases","volume":"10","author":"Xu","year":"2018","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.joim.2021.07.004_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/641865","article-title":"The TLR4\/TRIF-mediated activation of NLRP3 inflammasome underlies endotoxin-induced liver injury in mice","volume":"2010","author":"Tsutsui","year":"2010","journal-title":"Gastroent Res Pract"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.joim.2021.07.004_b0095","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.3748\/wjg.v23.i23.4146","article-title":"Antioxidant dietary approach in treatment of fatty liver: new insights and updates","volume":"23","author":"Ferramosca","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.joim.2021.07.004_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7109270","article-title":"A comprehensive updated review of pharmaceutical and nonpharmaceutical treatment for NAFLD","volume":"2016","author":"Hossain","year":"2016","journal-title":"Gastroenterol Res Pract."},{"issue":"4","key":"10.1016\/j.joim.2021.07.004_b0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3736\/jintegrmed2013034","article-title":"Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis","volume":"11","author":"Song","year":"2013","journal-title":"J Integr Med"},{"key":"10.1016\/j.joim.2021.07.004_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6491420","article-title":"A review of Western and traditional Chinese medical approaches to managing nonalcoholic fatty liver disease","volume":"2016","author":"Hsu","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12967-015-0383-6","article-title":"Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles","volume":"13","author":"Yuan","year":"2015","journal-title":"J Transl Med"},{"issue":"30","key":"10.1016\/j.joim.2021.07.004_b0120","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","article-title":"Herbal medicines and nonalcoholic fatty liver disease","volume":"22","author":"Yao","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.joim.2021.07.004_b0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11655-018-2829-6","article-title":"Effect of soothing Gan (liver) and invigorating Pi (spleen) recipes on TLR4-p38 MAPK pathway in Kupffer cells of non-alcoholic steatohepatitis rats","volume":"25","author":"Gong","year":"2019","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.joim.2021.07.004_b0130","doi-asserted-by":"crossref","first-page":"8479680","DOI":"10.1155\/2019\/8479680","article-title":"Chinese herbal medicine formula Shenling Baizhu San ameliorates high-fat diet-induced NAFLD in rats by modulating hepatic microRNA expression profiles","volume":"2019","author":"Pan","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.joim.2021.07.004_b0135","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.biopha.2018.03.158","article-title":"Effects of Shenling Baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2021.07.004_b0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jep.2019.03.006","article-title":"Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXR-\u03b1, PPAR-\u03b3, and NF-\u03baB-iNOS-NO signaling pathways","volume":"236","author":"Suolang","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.joim.2021.07.004_b0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","article-title":"Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice","volume":"806","author":"Sun","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.joim.2021.07.004_b0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1530\/JOE-17-0233","volume":"235","author":"Lee","year":"2017","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.joim.2021.07.004_b0155","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/ijms18051063","article-title":"Ginsenoside Rb2 alleviates hepatic lipid accumulation by restoring autophagy via induction of Sirt1 and activation of AMPK","volume":"18","author":"Huang","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.joim.2021.07.004_b0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2017.06.008","article-title":"Human germline hedgehog pathway mutations predispose to fatty liver","volume":"67","author":"Guillen-Sacoto","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.joim.2021.07.004_b0165","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.joim.2021.07.004_b0170","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.joim.2021.07.004_b0175","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1478-3231.2008.01691.x","article-title":"Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies","volume":"28","author":"Myers","year":"2008","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.joim.2021.07.004_b0180","first-page":"2952","article-title":"Euphorbia supina extract results in inhibition of high-fat-diet-induced obesity in mice","volume":"41","author":"Nepali","year":"2018","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.joim.2021.07.004_b0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.joim.2021.07.004_b0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.dld.2012.11.010","article-title":"Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies","volume":"45","author":"Frasinariu","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.joim.2021.07.004_b0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.joim.2021.07.004_b0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.joim.2021.07.004_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.redox.2018.02.007","article-title":"Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: antioxidant action of butyrate","volume":"16","author":"Yuan","year":"2018","journal-title":"Redox Biol"},{"issue":"7384","key":"10.1016\/j.joim.2021.07.004_b0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.joim.2021.07.004_b0215","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00213-019-05210-6","article-title":"Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice","volume":"236","author":"Fu","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.joim.2021.07.004_b0220","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/678627","article-title":"The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders","volume":"2013","author":"Benetti","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.joim.2021.07.004_b0225","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"6151","key":"10.1016\/j.joim.2021.07.004_b0230","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"341","author":"Kayagaki","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.joim.2021.07.004_b0235","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.26031","article-title":"Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition?","volume":"56","author":"Wattacheril","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.joim.2021.07.004_b0240","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2018.01.017","article-title":"Pyroptosis: an inflammatory link between NAFLD and NASH with potential therapeutic implications","volume":"68","author":"Beier","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.joim.2021.07.004_b0245","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.joim.2021.07.004_b0250","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/apha.12686","article-title":"Crosstalk between adipokines and myokines in fat browning","volume":"219","author":"Rodr\u00edguez","year":"2017","journal-title":"Acta Physiol"},{"key":"10.1016\/j.joim.2021.07.004_b0255","first-page":"1","article-title":"Plant extracts in prevention of obesity","volume":"15","author":"Wang","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0260","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00926.2007","article-title":"Inflammation is associated with a decrease of lipogenic factors in omental fat in women","volume":"295","author":"Poulain-Godefroy","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.joim.2021.07.004_b0265","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biopha.2017.10.035","article-title":"Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism","volume":"97","author":"Zhou","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.joim.2021.07.004_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 inflammasome in the progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2021.07.004_b0275","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.joim.2021.07.004_b0280","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hep.25932","article-title":"Elovl6 promotes nonalcoholic steatohepatitis","volume":"56","author":"Matsuzaka","year":"2012","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.joim.2021.07.004_b0285","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"10.1016\/j.joim.2021.07.004_b0290","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-2007-982502","article-title":"Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus","volume":"39","author":"Catal\u00e1n","year":"2007","journal-title":"Horm Metab Res"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496421000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:51:03Z","timestamp":1761864663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496421000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2095496421000649"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2021.07.004","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4\/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2021.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by ELSEVIER B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}